C. Bertelli

发表

Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

P. Mannucci, S. Fargion, F. Peyvandi, 2014, Journal of hepatology.

Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP).

A. Craxì, S. Petta, V. Calvaruso, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

E. Taioli, S. Fargion, A. Fracanzani, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown

S. Fargion, M. Vecchi, A. Fracanzani, 2022, Nutrients.

Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.

M. Mattioli, M. Stazi, S. Fargion, 2001, Blood cells, molecules & diseases.

High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: Preliminary results.

D. Consonni, S. Fargion, A. Fracanzani, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

H. Tjalsma, B. Motta, L. Valenti, 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

L. N. Valenti, M. Stazi, S. Fargion, 2005, Blood cells, molecules & diseases.

315 I148M PNPLA3 POLYMORPHISM IS ASSOCIATED WITH CLINICAL FEATURES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

L. N. Valenti, M. Colombo, B. Motta, 2012 .

Liver, Pancreas and Bilary Tract I susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary

E. Taioli, L. Valenti, S. Fargion, 2003 .

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

L. N. Valenti, G. Marchesini, E. Bugianesi, 2008, Hepatology.

Palliative care for the oldest old: recommendations from the first Italian Consensus Conference

G. Zaninetta, F. Nicoli, D. Chiesa, 2019 .

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.

D. Consonni, A. Catapano, S. Fargion, 2016, Atherosclerosis.

PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma

L. N. Valenti, M. Colombo, B. Motta, 2013, PloS one.

Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease.

E. Taioli, S. Fargion, A. Fracanzani, 2001, Journal of hepatology.

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease

D. Consonni, G. Norata, A. Catapano, 2016, PloS one.

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population.

G. Norata, K. Garlaschelli, A. Catapano, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease

Antonio Grieco, L. N. Valenti, Cristina Bertelli, 2012, PloS one.

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

D. Swinkels, H. Tjalsma, B. Motta, 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

L. N. Valenti, S. Fargion, L. Burdick, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.